Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Sonoma Pharmaceuticals revenue
Sonoma Pharmaceuticals's revenue is $12.7 million.
What is Sonoma Pharmaceuticals's revenue?
- Sonoma Pharmaceuticals's revenue growth from 2005 to 2023 is 392.84%.
- Sonoma Pharmaceuticals has 253 employees, and the revenue per employee ratio is $50,335.
- Sonoma Pharmaceuticals's peak quarterly revenue was $5.8M in 2020(q2).
- Sonoma Pharmaceuticals peak revenue was $19.0M in 2018.
- Sonoma Pharmaceuticals annual revenue for 2022 was 13.3M, 5.1% growth from 2021.
- Sonoma Pharmaceuticals annual revenue for 2023 was 12.7M, -4.05% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Sonoma Pharmaceuticals historical revenue
Sonoma Pharmaceuticals's peak revenue was $19.0M in 2018. The peak quarterly revenue was $5.8M in 2020(q2).
Sonoma Pharmaceuticals's revenue increased from $2.6m in 2005 to $12.7M currently. That's a 392.84% change in annual revenue.
Sonoma Pharmaceuticals annual revenue
Sonoma Pharmaceuticals annual revenue over time
| Fiscal year / year | Sonoma Pharmaceuticals revenue |
|---|---|
| 2009 | $7.4M |
| 2010 | $9.8M |
| 2011 | $12.7M |
| 2012 | $15.5M |
| 2013 | $13.7M |
| 2014 | $13.9M |
| 2015 | $9.4M |
| 2016 | $12.8M |
| 2017 | $16.7M |
| 2018 | $19.0M |
| 2019 | $17.9M |
| 2020 | $18.6M |
| 2021 | $12.6M |
| 2022 | $13.3M |
| 2023 | $12.7M |
How accurately did Sonoma Pharmaceuticals' revenue projections match actual performance?
Sonoma Pharmaceuticals annual growth
Sonoma Pharmaceuticals saw the greatest revenue growth in 2006, when revenue increased by 75.81%.
Sonoma Pharmaceuticals had the lowest revenue growth in 2015, when revenue changed by -32.37%.
Sonoma Pharmaceuticals annual growth rate over time
| Year | Sonoma Pharmaceuticals growth |
|---|---|
| 2009 | 37%↑ |
| 2010 | 32%↑ |
| 2011 | 31%↑ |
| 2012 | 21%↑ |
| 2013 | -12%↓ |
| 2014 | 1%↑ |
| 2015 | -32%↓ |
| 2016 | 37%↑ |
| 2017 | 30%↑ |
| 2018 | 14%↑ |
| 2019 | -5%↓ |
| 2020 | 4%↑ |
| 2021 | -32%↓ |
| 2022 | 5%↑ |
| 2023 | -4%↓ |
Sonoma Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Sonoma Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $1.8M | $1.7M | $1.6M | $2.2M |
| 2010 | $2.3M | $2.5M | $2.3M | $2.7M |
| 2011 | $2.9M | $3.7M | $2.8M | $3.4M |
| 2012 | $4.1M | $4.5M | $3.5M | $3.3M |
| 2013 | $3.4M | $4.1M | $3.3M | $2.9M |
| 2014 | $3.4M | $3.3M | $3.2M | $4.0M |
| 2015 | $3.7M | $4.1M | $2.5M | $2.6M |
| 2016 | $2.6M | $2.8M | $3.4M | $4.0M |
| 2017 | $3.8M | $4.3M | $4.8M | $3.7M |
| 2018 | $4.4M | $4.9M | $5.3M | $4.4M |
| 2019 | $4.5M | $4.7M | $4.4M | $4.3M |
| 2020 | $5.8M | $5.8M | $4.9M | $2.2M |
| 2021 | $3.7M | $3.7M | $2.9M | $2.3M |
| 2022 | $4.0M | $3.3M | $2.9M | $3.0M |
| 2023 | $3.4M | $2.7M | $3.1M | $3.4M |
| 2024 | $3.4M | $3.6M | $3.6M | - |
Sonoma Pharmaceuticals jobs nearby
Do you work at Sonoma Pharmaceuticals?
Is Sonoma Pharmaceuticals transparent about its revenue structure?
Sonoma Pharmaceuticals financial information
| CEO | Amy M. Trombly |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 253 |
| Date Founded | 1999 |
| Headquarters | Petaluma, California |
| Number of Locations | 2 |
| Revenue | $12.7M |
| Net Income | -$5,151,000 |
| Gross Proft | $4.7M (2023) |
| Tax Rate | 0.0% |
| Total Assets | $16,231,000 |
| Ticker | SNOA |
Sonoma Pharmaceuticals jobs you might like
Sonoma Pharmaceuticals financing
Sonoma Pharmaceuticals received early financing of $4.6M on 2018-03-06.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $4.6M | 03/2018 |
| Post Ipo Equity | $1.6M | 11/2019 |
| Post Ipo Equity | $70M | 09/2020 |
Sonoma Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Montreux Equity Partners | Post Ipo Equity |
| Lilly Asia Ventures | Post Ipo Equity |
| JDRF T1D Fund | Post Ipo Equity |
| Eight Partners VC LLC | Post Ipo Equity |
| ARCH Venture Partners | Post Ipo Equity |
| Lifeforce Capital | Post Ipo Equity |
| LYELL IMMUNOPHARMA INC. | Post Ipo Equity |
| Alexandria Venture Investments | Post Ipo Equity |
| Octagon Capital Partners Inc | Post Ipo Equity |
Sonoma Pharmaceuticals revenue FAQs
Search for jobs
Sonoma Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Sonoma Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sonoma Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Sonoma Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sonoma Pharmaceuticals. The data presented on this page does not represent the view of Sonoma Pharmaceuticals and its employees or that of Zippia.
Sonoma Pharmaceuticals may also be known as or be related to Sonoma Pharmaceuticals, Sonoma Pharmaceuticals Inc, Sonoma Pharmaceuticals Inc. and Sonoma Pharmaceuticals, Inc.